Evidence map›Paper›PMID 36707143›Full record

ArticleVitamins and hormones2023

Hydrogen peroxide detoxification through the peroxiredoxin/thioredoxin antioxidant system: A look at the pancreatic β-cell oxidant defense.

Jennifer S Stancill, John A Corbett

Abstract read
In one paragraph

Article in Vitamins and hormones, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Nanomedicine-Driven Modulation of Reductive Stress for Cancer Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jennifer S StancillDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, United States.
John A CorbettDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, United States. Electronic address: jcorbett@mcw.edu.

Funding

BIOCHEMICAL MECHANISM OF BETA-CELL DESTRUCTIONR01DK052194 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CORBETT, JOHN A · 1998 to 2025
$8.8M
MECHANISMS OF VIRAL INDUCED BETA CELL DAMAGER01AI044458 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CORBETT, JOHN A · 1998 to 2024
$7.5M
Protective Mechanisms in Pancreatic Beta-cellsK99DK129709 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI STANCILL, JENNIFER SUSAN · 2021 to 2022
$180k
NIAID NIH HHS R01 AI044458NIDDK NIH HHS K99 DK129709NIDDK NIH HHS R01 DK052194
6 · The paper itself

Abstract

Reactive oxygen species (ROS), such as hydrogen peroxide, are formed when molecular oxygen obtains additional electrons, increasing its reactivity. While low concentrations of hydrogen peroxide are necessary for regulation of normal cellular signaling events, high concentrations can be toxic. To maintain this balance between beneficial and deleterious concentrations of hydrogen peroxide, cells utilize antioxidants. Our recent work supports a primary role for peroxiredoxin, thioredoxin, and thioredoxin reductase as the oxidant defense pathway used by insulin-producing pancreatic β-cells. These three players work in an antioxidant cycle based on disulfide exchange, with oxidized targets ultimately being reduced using electrons provided by NADPH. Peroxiredoxins also participate in hydrogen peroxide-based signaling through disulfide exchange with redox-regulated target proteins. This chapter will describe the catalytic mechanisms of thioredoxin, thioredoxin reductase, and peroxiredoxin and provide an in-depth look at the roles these enzymes play in antioxidant defense pathways of insulin-secreting β-cells. Finally, we will evaluate the physiological relevance of peroxiredoxin-mediated hydrogen peroxide signaling as a regulator of β-cell function.

Indexed as

AntioxidantsInsulinsHumansHydrogen PeroxideOxidantsOxidative StressPeroxiredoxinsThioredoxin-Disulfide ReductaseThioredoxinsAntioxidantsHydrogen PeroxideInsulinsOxidantsPeroxiredoxinsThioredoxin-Disulfide ReductaseThioredoxinsBeta-cellsDiabetesHydrogen peroxidePeroxiredoxinROSThioredoxinThioredoxin reductase

Identifiers

PMID36707143
PMCPMC10058777

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.